VGLL1 Polyclonal antibody 10124-2-AP proteintech

$149.00
In stock
SKU
10124-2-AP
Catalog No.SizePrice (USD)
10124-2-AP-20UL20 μL$149.00
10124-2-AP-150UL150 μL$449.00
Catalog Number10124-2-AP
SynonymsProtein TONDU, TDU, vestigial like 1 (Drosophila), Vgl 1, VGL1, VGLL1
HostRabbit
Reactivityhuman, mouse, rat
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF, IP, RIP, ELISA
ApplicationsWB, IHC, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inJurkat cells, human brain tissue, rat brain tissue, PC-3 cells, mouse brain tissue, mouse spleen tissue, rat spleen tissue
Tested Applications — Positive IHC detected inhuman prostate cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Recommended Dilutions — Western Blot (WB)WB : 1:1000-1:6000
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:20-1:200
Positive WB detected inJurkat cells, human brain tissue, rat brain tissue, PC-3 cells, mouse brain tissue, mouse spleen tissue, rat spleen tissue
Positive IHC detected inhuman prostate cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Western Blot (WB)WB : 1:1000-1:6000
Immunohistochemistry (IHC)IHC : 1:20-1:200
Tested Reactivityhuman, mouse, rat
Cited Reactivityhuman, mouse
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag0169 Product name: Recombinant human VGLL1 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 38-255 aa of BC000045 Sequence: SSVVDEHFSRALSNIKSPQELTPSSQSEGVMLKNDDSMSPNQWRYSSPWTKPQPEVPVTNRAANCNLHVPGPMAVNQFSPSLARRASVRPGELWHFSSLAGTSSLEPGYSHPFPARHLVPEPQPDGKREPLLSLLQQDRCLARPQESAARENGNPGQIAGSTGLLFNLPPGSVHYKKLYVSRGSASTSLPNETLSELETPGKYSLTPPNHWGHPHRYL Predict reactive species
Full Namevestigial like 1 (Drosophila)
Calculated Molecular Weight29 kDa
Observed Molecular Weight26-29 kDa
GenBank Accession NumberBC000045
Gene SymbolVGLL1
Gene ID (NCBI)51442
RRIDAB_2218174
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDQ99990
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IHC protocol for VGLL1 antibody 10124-2-APDownload protocol
WB protocol for VGLL1 antibody 10124-2-APDownload protocol
humanWB Cancer Res Induction of the TEAD Co-activator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer Authors - Carolina Gemma KD Validated View Article
human,mouseWB,IHC,IF,RIP iScience N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling Authors - Han Li View Article
Jennifer (Verified Customer) (06-10-2022)Applications: Western Blot Primary Antibody Dilution: 1:1000 Cell Tissue Type: human urothelial cells
Citations7
DilutionsWB : 1:1000-1:6000 IHC : 1:20-1:200
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

VGLL1 is a specific coactivator for the mammalian TEFs. It can bind proteins of the TEA domain family of transcription factors. Vgll1-TEFs complex upregulates the expression of IGFBP-5, a proliferation-promoting gene, and facilitates anchorage-independent cell proliferation. The calculated molecular weight of VGLL1 is 29 kDa, and the observed molecular weight is 26-29 kDa(PMID:31816819,33087697). Protocols Product Specific Protocols IHC protocol for VGLL1 antibody 10124-2-AP Download protocol WB protocol for VGLL1 antibody 10124-2-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. Vgll1 expression is associated with a triple-negative basal-like phenotype in breast cancer.
    Journal: Endocr Relat Cancer | Authors: María Ángeles Castilla
  2. PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer.
    Journal: Cancers (Basel) | Authors: Bo-Kyung Kim KD Validated | Species: human | Application: WB,IHC
  3. N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling
    Journal: iScience | Authors: Han Li | Species: human,mouse | Application: WB,IHC,IF,RIP
  4. Placental co-transcriptional activator Vestigial-like 1 (VGLL1) drives tumorigenesis via increasing transcription of proliferation and invasion genes
    Journal: Front Oncol | Authors: Heather M Sonnemann | Species: human | Application: WB,IP
  5. TNF−α Secreted from Macrophages Increases the Expression of Prometastatic Integrin αV in Gastric Cancer
    Journal: Int J Mol Sci | Authors: Mi-Aie Hwang KD Validated | Species: human | Application: WB
  6. Induction of the TEAD Co-activator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer
    Journal: Cancer Res | Authors: Carolina Gemma KD Validated | Species: human | Application: WB
  7. Placental co-transcriptional activator Vestigial-like 1 (VGLL1) drives tumorigenesis via increasing transcription of proliferation and invasion genes
    Journal: Front Oncol | Authors: Heather M Sonnemann | Species: human | Application: WB,IP

Product Documents

Datasheet

Datasheet

Reviews

Write Your Own Review
You're reviewing:VGLL1 Polyclonal antibody 10124-2-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.